You searched for | Enterprise Therapeutics

Phone: +44 (0)1273 234667 | Email: info@enterprisetherapeutics.com

Home
About Us
Scientific Strategy
Pipeline
Publications, News & Events
Contact Us
Menu

You are here: Home / Search results for ""

New Search

If you are not happy with the results below please do another search

Pages

Categories

News
Publications

Archive

April 2019
March 2019
February 2019
October 2018
September 2018
April 2018
March 2018
September 2017
June 2017
April 2017
February 2017
November 2016
October 2016
March 2016
May 2015
February 2015

ENTERPRISE THERAPEUTICS

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. The company is based in the UK with offices at the Sussex Innovation Centre.

Latest News

The pharmacology of novel TMEM16A potentiator compoundsApril 2, 2019 - 10:54 am
TMEM16A channel function does not influence goblet cell numbers in the human airway epitheliumApril 2, 2019 - 10:51 am
E_ACT increases intracellular calcium levels by a TMEM16A-independent mechanismApril 2, 2019 - 10:41 am
Enterprise Therapeutics strengthens leadership team, appoints Amit D. Munshi as Non-Executive ChairmanMarch 25, 2019 - 9:35 am

Follow Us On Twitter

Enterprise Therapeutics @EnterpriseThera·

A new report from @asthmauk has found that deaths from #asthma attacks are the highest they have been in the last decade & have increased by more than 33% over the last 10 years. This highlights the urgent need for novel #therapies. Read more @PharmaTimes: https://t.co/pQrj8rxiQE

Reply on Twitter 1164112049359732737 Retweet on Twitter 1164112049359732737 Like on Twitter 1164112049359732737 Follow us on Twitter 1164112049359732737

Contact Us

Sussex Innovation Centre,
University of Sussex,
Science Park Square,
Falmer, Brighton, BN1 9SB

info@enterprisetherapeutics.com
+44 (0)1273 234667

Privacy & Cookie Policy

© Copyright - Enterprise Therapeutics - powered by Enfold WordPress Theme

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

For more details, please click here OK